Reimbursement Strategy

TariffPath

TariffPath is a specialist commercial support service created specifically to help community-reimbursed medical device manufacturers succeed through Part IX Drug Tariff reform.

We enable UK Part IX brand owners to anticipate and interpret DHSC reimbursement changes and take decisive commercial action ahead of revenue or patient impact.

We need your consent to load the translations

We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.